(Q46790430)

English

Residual platelet thromboxane A2 and prothrombotic effects of erythrocytes are important determinants of aspirin resistance in patients with vascular disease

scientific article published on 23 January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18221358

Residual platelet thromboxane A2 and prothrombotic effects of erythrocytes are important determinants of aspirin resistance in patients with vascular disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18221358

1 reference

based on heuristic

inferred from title

author name string

M T Santos

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18221358

J Valles

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18221358

A Lago

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18221358

J Tembl

4

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18221358

E Sánchez

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18221358

A Moscardo

6

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18221358

J Cosin

7

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18221358

publication date

23 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18221358

Journal of Thrombosis and Haemostasis

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18221358

6

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18221358

4

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18221358

615-621

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18221358

Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02915.X

21 January 2018

Aspirin and clopidogrel resistance: an emerging clinical entity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02915.X

21 January 2018

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02915.X

21 January 2018

Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02915.X

21 January 2018

Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02915.X

21 January 2018

Persistent production of platelet thromboxane A2 in patients chronically treated with aspirin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02915.X

21 January 2018

Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02915.X

21 January 2018

Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02915.X

21 January 2018

Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02915.X

21 January 2018

Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality: the effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of eryt

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02915.X

21 January 2018

Aspirin therapy for inhibition of platelet reactivity in the presence of erythrocytes in patients with vascular disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02915.X

21 January 2018

Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02915.X

21 January 2018

Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02915.X

21 January 2018

Effects of low dose aspirin on platelet function in patients with recent cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02915.X

21 January 2018

Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02915.X

21 January 2018

De novo synthesis of cyclooxygenase-1 counteracts the suppression of platelet thromboxane biosynthesis by aspirin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02915.X

21 January 2018

Nucleotide receptor signaling in platelets

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02915.X

21 January 2018

Coordinated signaling through both G12/13 and G(i) pathways is sufficient to activate GPIIb/IIIa in human platelets

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02915.X

21 January 2018

Evidence for cross-talk between glycoprotein VI and Gi-coupled receptors during collagen-induced platelet aggregation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02915.X

21 January 2018

Platelet-erythrocyte interactions enhance alpha(IIb)beta(3) integrin receptor activation and P-selectin expression during platelet recruitment: down-regulation by aspirin ex vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02915.X

21 January 2018

Pharmacokinetic and pharmacodynamic differences between two low dosages of aspirin may affect therapeutic outcomes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02915.X

21 January 2018

Partial inhibition of platelet thromboxane A2 synthesis by aspirin is associated with myonecrosis in patients with ST-segment elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02915.X

21 January 2018

Identifiers

10.1111/J.1538-7836.2008.02915.X

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18221358

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18221358

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46790430&oldid=2134080823"